SCHEMBL5199665

SCHEMBL5199665

C=Cc1ccc(COC(C)(C)C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
TSHR P16473 2/20 0.34
HDAC8 Q9BY41 1/20 0.34
TRPA1 O75762 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
HIF1A Q16665 1/20 0.31
TP53 P04637 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4460590 0.85 ALDH1A1 (0.41) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL21132914 0.84 ALDH1A1 (0.37) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL648537 0.82 AGXT (0.39) TSHR
SCHEMBL188150 0.82 ALDH1A1 (0.38) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL22505546 0.81 ALDH1A1 (0.41) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL21189669 0.80 ALDH1A1 (0.37) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL18812345 0.78 TP53 (0.44) ALDH1A1TSHRHDAC8TRPA1TDP1
SCHEMBL7936416 0.78 ALDH1A1 (0.38) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL13046083 0.78 ALDH1A1 (0.34) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL19429021 0.77 ALDH1A1 (0.41) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230309369-A1 Organic Light-Emitting Device LG CHEM, LTD. (KR) 2023-09-28 US disclosed
US-20230309369-A1 Organic Light-Emitting Device LG CHEM, LTD. (KR) 2023-09-28 US disclosed
US-11765921-B2 Ionic compound, and coating composition and organic light-emitting device comprising same LG CHEM, LTD. 2023-09-19 US disclosed
US-11765921-B2 Ionic compound, and coating composition and organic light-emitting device comprising same LG CHEM, LTD. 2023-09-19 US disclosed
US-11737300-B2 Coating composition and organic light-emitting device LG CHEM, LTD. (KR) 2023-08-22 US disclosed
US-11737300-B2 Coating composition and organic light-emitting device LG CHEM, LTD. (KR) 2023-08-22 US disclosed
US-11702550-B2 Coating composition, organic light-emitting diode using same, and method for preparing same LG CHEM, LTD. 2023-07-18 US disclosed
US-11702550-B2 Coating composition, organic light-emitting diode using same, and method for preparing same LG CHEM, LTD. 2023-07-18 US disclosed
US-11572346-B2 Compound, coating composition comprising same, and organic light-emitting device LG CHEM, LTD. 2023-02-07 US disclosed
US-11472966-B2 Coating composition, organic light-emitting diode using same and method for preparing same LG CHEM, LTD. 2022-10-18 US disclosed
US-20090092554-A1 ENCAPSULATED CONTRAST AGENTS INTEZYNE TECHNOLOGIES, INC. (US) 2009-04-09 US disclosed
US-20080274173-A1 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 US disclosed
US-20080274965-A1 ENCAPSULATED AMYLOID-BETA PEPTIDES INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 US disclosed
EP-1481981-B1 Styrene hypophosphite adduct, preparation thereof and use CLARIANT PRODUKTE DEUTSCHLAND (DE) 2007-08-15 EP disclosed
US-7220791-B2 Styrene-hypophosphite adduct, a process for preparation thereof, and its use CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) 2007-05-22 US disclosed
US-20040242738-A1 Styrene-hypophosphite adduct, a process for preparation thereof, and its use CLARIANT GMBH 2004-12-02 US disclosed
EP-1481981-A2 Styrene hypophosphite adduct, preparation thereof and use Clariant GmbH (DE) 2004-12-01 EP disclosed
US-6486272-B1 METAL COMPOUND INTERACTS WITH A VINYL COMPOUND WITH A FUNCTIONAL GROUP TO MASK IT AND COPOLYMERIZING WITH A STYRENE IN THE PRESENCE OF TRANSITION METAL COMPOUND, OXYGEN COMPOUNDS WHICH FORM IONIC COMPLEXES, AND AN ORGANOMETALLIC COMPOUND IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2002-11-26 US disclosed
US-20020173605-A1 PROCESS FOR PRODUCING FUNCTIONAL STYRENE COPOLYMER AND FUNCTIONAL STYRENE COPOLYMER IDEMITSU KOSAN CO.,LTD. (JP) 2002-11-21 US disclosed
EP-1219649-A1 PROCESS FOR PRODUCING FUNCTIONAL STYRENE COPOLYMER AND FUNCTIONAL STYRENE COPOLYMER IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2002-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080274965-A1 ENCAPSULATED AMYLOID-BETA PEPTIDES IAPP, APP, TTR ALDH1A1 4688/4885CHRNB2 398/4885CHRNB4 673/4885
US-11572346-B2 Compound, coating composition comprising same, and organic light-emitting device OR10J3, CRY1, CRY2 ALDH1A1 1186/4885CHRNB2 1406/4885CHRNB4 1741/4885
US-11472966-B2 Coating composition, organic light-emitting diode using same and method for preparing same OR10J3, SEM1, ORMDL3 ALDH1A1 134/4885CHRNB2 1620/4885CHRNB4 2141/4885
US-11765921-B2 Ionic compound, and coating composition and organic light-emitting device comprising same OR10J3, ORC3, CD59 ALDH1A1 2311/4885CHRNB2 448/4885CHRNB4 612/4885
US-20090092554-A1 ENCAPSULATED CONTRAST AGENTS LIPA, LPXN, CD47 ALDH1A1 3588/4885CHRNB2 3063/4885CHRNB4 3252/4885
US-20080274173-A1 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery CLTB, SLC1A5, CLTA ALDH1A1 3966/4885CHRNB2 2586/4885CHRNB4 2856/4885
US-11737300-B2 Coating composition and organic light-emitting device CD59, CLTB, EPCAM ALDH1A1 2135/4885CHRNB2 368/4885CHRNB4 490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.